# Avalglucosidase Alfa Pregnancy Study

> **NCT05734521** · — · RECRUITING · sponsor: **Sanofi** · enrollment: 100 (estimated)

## Conditions studied

- Pompe Disease
- Pregnancy

## Interventions

- **BIOLOGICAL:** avalglucosidase alfa-NGPT (GZ402666) IV
- **BIOLOGICAL:** avalglucosidase alfa-NGPT (GZ402666)

## Key facts

- **NCT ID:** NCT05734521
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-26
- **Primary completion:** 2032-10-31
- **Final completion:** 2032-10-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734521, "Avalglucosidase Alfa Pregnancy Study". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05734521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*